Complex intervention including pain science education and patient-led goal setting-based self-management strategies for management of aromatase inhibitor-induced musculoskeletal symptoms: a single-arm feasibility and pilot study.

Purpose: Up to 74% of breast cancer survivors (BCS) treated with aromatase inhibitor (AI) experience AI-induced musculoskeletal symptoms (AIMSS). AIMSS is the predominant cause of poor adherence to AI therapy, yet no definitive treatment exists. The primary research objectives of this study were (1) to develop a novel BCS-specific complex intervention to alleviate AIMSS, and to assess its feasibility.

Electrocardiogram measurement during sleep with wearing clothes using capacitively-coupled electrodes.

The electrocardiogram (ECG) was measured by non-contact, non-restraint and unconscious method using capacitively-coupled electrodes made of electro-conductive cloth while subjects lay on bed wearing their clothes. These electrodes are very sensitive so measure not only signals but noise. The seat grounded, which arranged under the electrode could suppress noise.